Romosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis.

Song, Gwan G

Romosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis. [electronic resource] - The New England journal of medicine 01 2018 - 194 p. digital

Publication Type: Letter; Comment

1533-4406

10.1056/NEJMc1714810 doi


Alendronate
Antibodies, Monoclonal
Female
Fractures, Bone
Humans
Osteoporosis